Catalent Inc
NYSE:CTLT

Watchlist Manager
Catalent Inc Logo
Catalent Inc
NYSE:CTLT
Watchlist
Price: 63.48 USD Market Closed
Market Cap: 11.5B USD

Relative Value

The Relative Value of one CTLT stock under the Base Case scenario is hidden USD. Compared to the current market price of 63.48 USD, Catalent Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CTLT Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
39
vs Industry
43
Median 3Y
2.5
Median 5Y
2.6
Industry
2.7
Forward
2.4
vs History
vs Industry
0
Median 3Y
-25.7
Median 5Y
-5.7
Industry
21.6
Forward
56.2
vs History
66
vs Industry
15
Median 3Y
28.8
Median 5Y
37.8
Industry
16.9
vs History
vs Industry
Median 3Y
-52.9
Median 5Y
-42
Industry
22.9
vs History
34
vs Industry
23
Median 3Y
2.8
Median 5Y
3.2
Industry
2.3
vs History
36
vs Industry
32
Median 3Y
3.5
Median 5Y
3.6
Industry
3
Forward
3.4
vs History
26
vs Industry
13
Median 3Y
16.6
Median 5Y
16.4
Industry
5.6
vs History
9
vs Industry
10
Median 3Y
36.3
Median 5Y
25.9
Industry
13.4
Forward
19.5
vs History
vs Industry
11
Median 3Y
-334.2
Median 5Y
20.2
Industry
16.7
Forward
35.8
vs History
65
vs Industry
10
Median 3Y
41.2
Median 5Y
45
Industry
16.1
vs History
1
vs Industry
3
Median 3Y
-27.9
Median 5Y
-48.4
Industry
18.9
vs History
34
vs Industry
38
Median 3Y
1.6
Median 5Y
1.8
Industry
2

Multiples Across Competitors

CTLT Competitors Multiples
Catalent Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Catalent Inc
NYSE:CTLT
11.5B USD 2.6 -27.8 36.3 -334.2
US
Eli Lilly and Co
NYSE:LLY
1T USD 16.9 54.6 36.7 39.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
491.8B USD 5.3 19.6 16 20.8
CH
Roche Holding AG
SIX:ROG
271.4B CHF 4.4 28.8 12.2 14.3
UK
AstraZeneca PLC
LSE:AZN
220.4B GBP 5.1 31.4 109 159.5
US
Merck & Co Inc
NYSE:MRK
274.9B USD 4.3 14.4 10.2 12.1
CH
Novartis AG
SIX:NOVN
218.8B CHF 4.9 19 12 15.5
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK 5.4 16.3 11.3 13.2
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
144.9B USD 2.3 14.7 7.5 10.2
P/E Multiple
Earnings Growth PEG
US
Catalent Inc
NYSE:CTLT
Average P/E: 24.9
Negative Multiple: -27.8
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
54.6
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.6
29%
0.7
CH
Roche Holding AG
SIX:ROG
28.8
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.4
37%
0.8
US
Merck & Co Inc
NYSE:MRK
14.4
15%
1
CH
Novartis AG
SIX:NOVN
19
17%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
16.3
3%
5.4
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.7
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Catalent Inc
NYSE:CTLT
Average EV/EBITDA: 403.3
36.3
32%
1.1
US
Eli Lilly and Co
NYSE:LLY
36.7
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16
9%
1.8
CH
Roche Holding AG
SIX:ROG
12.2
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
109
10%
10.9
US
Merck & Co Inc
NYSE:MRK
10.2
6%
1.7
CH
Novartis AG
SIX:NOVN
12
6%
2
DK
Novo Nordisk A/S
CSE:NOVO B
11.3
1%
11.3
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Catalent Inc
NYSE:CTLT
Average EV/EBIT: 1 883.6
Negative Multiple: -334.2
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.3
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
20.8
15%
1.4
CH
Roche Holding AG
SIX:ROG
14.3
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
159.5
23%
6.9
US
Merck & Co Inc
NYSE:MRK
12.1
8%
1.5
CH
Novartis AG
SIX:NOVN
15.5
12%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
13.2
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5